Rubicon Research Limited (RUBICON) Share Price
NSE · Healthcare · Drug Manufacturers - General · ISIN INE506V01022
Key metrics
- Market Cap
- ₹29,814 Cr
- P/E Ratio
- 103.19
- EPS
- 17.5
- Book Value
- 78.23
- P/B Ratio
- 23.08
- ROE
- 19.14%
- ROCE
- 22.26%
- Debt / Equity
- 0.24
- Net Margin
- 14.25%
- Revenue Growth
- 36.62%
- Profit Growth
- —
- Dividend Yield
- 0.08%
- 52W High
- ₹1,899.00
- 52W Low
- ₹570.75
- Market Cap Band
- large cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About Rubicon Research Limited
Rubicon Research Limited operates as a specialty pharmaceutical company in India, the United States, and internationally. Its primary proprietary technologies for drug delivery comprising RubiSRL for the formulation of sustained release liquids using a combination of ion exchange and membrane diffusion controlled-release technologies; and RubiReten, a gastro-retentive system for drugs with poor solubility and a limited window of absorption. The company develops products in the areas of analgesics/pain management, hypokalemia, gastrointestinal, cardiovascular, skeletal muscle relaxants, metabolic, central nervous system, nicotine replacement therapy, and immunosuppressant. The company was incorporated in 1999 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
- Employees
- 1,290
- Promoter Holding
- 77.59%
The full Rubicon Research Limited analysis
Create a free account to open the complete RUBICON deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.